PA
IBB icon

Procyon Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Procyon Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420K Hold
2,210
– – 0.02% 393
2026
Q1 		$373K Sell
2,210
-30
-1% -$5.13K 0.02% 406
2025
Q4 		$378K Hold
2,240
– – 0.02% 380
2025
Q3 		$323K Sell
2,240
-519
-19% -$70.8K 0.02% 392
2025
Q2 		$349K Buy
2,759
+430
+18% +$52.8K 0.03% 346
2025
Q1 		$298K Hold
2,329
– – 0.02% 487
2024
Q4 		$308K Hold
2,329
– – 0.02% 435
2024
Q3 		$339K Hold
2,329
– – 0.02% 426
2024
Q2 		$320K Hold
2,329
– – 0.02% 406
2024
Q1 		$320K Hold
2,329
– – 0.02% 409
2023
Q4 		$316K Hold
2,329
– – 0.03% 405
2023
Q3 		$285K Buy
2,329
+52
+2% +$6.61K 0.03% 403
2023
Q2 		$289K Buy
2,277
+24
+1% +$3.12K 0.04% 366
2023
Q1 		$291K Sell
2,253
-250
-10% -$32.7K 0.05% 317
2022
Q4 		$329K Sell
2,503
-100
-4% -$12.9K 0.06% 274
2022
Q3 		$304K Hold
2,603
– – 0.07% 242
2022
Q2 		$306K Sell
2,603
-640
-20% -$76K 0.07% 253
2022
Q1 		$423K Buy
3,243
+610
+23% +$79.5K 0.09% 208
2021
Q4 		$402K Sell
2,633
-142
-5% -$22K 0.09% 208
2021
Q3 		$449K Buy
2,775
+750
+37% +$126K 0.11% 177
2021
Q2 		$331K Buy
2,025
+335
+20% +$51.6K 0.09% 195
2021
Q1 		$254K Hold
1,690
– – 0.11% 208
2020
Q4 		$256K Sell
1,690
-24
-1% -$3.43K 0.12% 191
2020
Q3 		$232K Hold
1,714
– – 0.13% 179
2020
Q2 		$234K Buy
1,714
+24
+1% +$3.06K 0.12% 161
2020
Q1 		$182K Sell
1,690
-17
-1% -$1.96K 0.12% 164
2019
Q4 		$206K Buy
+1,707
New +$190K 0.13% 162

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Procyon Advisors's IBB Position: Q2 2026 in Review

Procyon Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 2,210 shares worth $420K. The position accounts for 0.02% of the portfolio, ranked #393.

Procyon Advisors first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $449K in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Procyon Advisors held 2,210 shares of iShares Biotechnology ETF worth $420K as of Q2 2026.
  • Procyon Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.02% of Procyon Advisors's portfolio in Q2 2026, its #393 holding.
  • Procyon Advisors first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • Procyon Advisors's iShares Biotechnology ETF position peaked at $449K in Q3 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.